Antimicrobial Resistance (AMR) is one of the top global public health threats, according to the World Health Organization (WHO). It endangers the foundation of modern medicine, making infections harder to treat—deadly even—and routine procedures riskier. At TAXIS Pharmaceuticals, Inc., we’re at the forefront of the fight against AMR. Our innovative investigational therapies are designed to restore the efficacy of existing antibiotics and address the growing global crisis of drug-resistant infections. Learn more about TAXIS’ groundbreaking research and how we’re working to turn the tide against AMR on our website: https://lnkd.in/gTDkiJKZ. #medicine #clinicalresearch #healthcare #biotech #innovation #partnerships #health #research #AMR #antibiotics #medtech #pharma #antibioticresistance #worldhealth #globalhealth #investments #startups #antimicrobialresistance #investments #pharmaceuticals #MRSA
关于我们
TAXIS Pharmaceuticals is a biotech company devoted to combatting the serious and deadly societal threat of antibiotic resistance by creating therapies that address the root cause of the issue. We're developing therapies that, when used in combination with FDA-approved antibiotics, are intended to restore the efficacy of those medications. We currently have one investigational therapy that has completed Ph1 human trials, and several additional products in the pipeline.
- 网站
-
https://www.taxispharma.com/
TAXIS Pharmaceuticals, Inc.的外部链接
- 所属行业
- 制药业
- 规模
- 2-10 人
- 类型
- 私人持股
地点
-
主要
获取路线
TAXIS Pharmaceuticals, Inc.员工
动态
-
Thanks to Global Antibiotic R&D Partnership (GARDP) for bringing awareness to this urgent global issue. Antimicrobial resistance (AMR) endangers the very foundation of modern medicine, making infections harder to treat—deadly even—and routine procedures riskier. TAXIS Pharmaceuticals, Inc. is committed to combating AMR and saving lives. Our investigational therapies are designed to directly address the root causes of AMR. Learn more on our website: https://lnkd.in/gVC97hgT. #medicine #clinicalresearch #healthcare #biotech #innovation #partnerships #health #research #AMR #antibiotics #medtech #pharma #antibioticresistance #worldhealth #globalhealth #investments #startups #antimicrobialresistance #investments #pharmaceuticals #MRSA #cancer
?? Fighting cancer means fighting drug resistance Nowhere is this issue more acute than in the United States. Despite leading in cancer care and innovation, cancer remains the second biggest killer. But without effective antibiotics, even the best treatments won’t be enough—patients surviving cancer could succumb to untreatable infections. The disparity in investment is stark: ?? Oncology investment surged by 900% to $7 billion, with cancer drug trials at record highs. ?? Antibiotic R&D, meanwhile, remains critically underfunded—just $160 million was raised in 2020. To fight cancer without also addressing drug resistance is not just a false economy but a major public health failure. If we are serious about tackling cancer, we must prioritize antibiotic development alongside new cancer treatments. ?? Read more in this opinion piece by Dr Manica Balasegaram. #AMR #CancerCare #AntibioticResistance #PublicHealth #PASTEURAct #Innovation
-
Thanks to MRUNAL GHARE for this informative article about the role disinfectants play in promoting antimicrobial resistance (AMR) and the need for innovative solutions in disinfection formulations. TAXIS Pharmaceuticals, Inc. is committed to combating AMR and saving lives. Our investigational therapies are designed to directly address the root causes of AMR. Learn more on our website: https://lnkd.in/gVC97hgT. #AMR #technology #antibioticresistant #nanotechnology #innovation #health #worldhealth #globalhealth #medicine #medtech #antibiotics #pharmaceuticals #superbugs #antibiotics #research #biotech #medtech #healthcare #antimicrobialresistance 360iResearch?
-
Antimicrobial Resistance (AMR) is one of the greatest threats to global health, with estimates predicting up to 10 million deaths annually by 2050. At TAXIS Pharmaceuticals, Inc., we refuse to let that future become a reality. Our groundbreaking research is dedicated to developing innovative therapies to combat multidrug-resistant bacterial infections, including hospital-acquired infections and MRSA. By targeting the root causes of bacterial resistance mechanisms, we aim to restore the effectiveness of antibiotics and protect future generations. How do we fight AMR? Learn more in our blog: “Overcoming Antibiotic Resistance: Breathing New Life into Old Medications.” https://bit.ly/4kZvcNq #research #innovation #startups #medtech #drugdiscovery #biotech #partnerships #biopharma #AMR #antimicrobialresistance #MRSA #antibioticresistance #globalhealth #publichealth #worldhealth #health #healthcare #medicine #HAI #pharmaceuticals #antibiotics
-
-
?? Superbugs are on the rise. ?? By 2050, antimicrobial resistance (AMR) could cause 10 million deaths annually—surpassing cancer as the leading global killer. The time to act is NOW. At TAXIS Pharmaceuticals, Inc., we are on a mission to develop next-generation antibiotics that outsmart drug-resistant bacteria. But scientific innovation alone isn’t enough—we need strong partnerships, investments, and policy support to bring these life-saving treatments to patients. ?? That’s why we’re thrilled to announce that Gregory G Mario, TAXIS’ CEO, will be presenting at BioFlorida, Inc.'s 9th Annual Life Sciences Showcase. This is an opportunity for scientists, investors, and healthcare leaders to join forces in the fight against AMR. ?? Don’t miss this discussion. If you are attending BioFlorida and would like to meet with us, please get in touch via our website. ( https://lnkd.in/gGXjsmEd). ?? When: March 19, 2025 Where: Miami International Airport Auditorium #AMR #Superbugs #Medicine #LifeSciences #Innovation #GlobalHealth #healthcare #Antimicrobialresistance #Biotech #medtech #healthcare #drugdevelopment #pharmaceuticals #healthcareinnovation #research #BioFlorida2025 #medicalinnovation
-
-
TAXIS Pharmaceuticals, Inc.转发了
Senior Engagement Partner | CCF | Translational Research | I help health systems and professionals from concept to commercialization, secure funding, and establish partnerships | 100+ medical technologies evaluated
South Florida is becoming a hotspot for life sciences innovation and collaboration is the real catalyst for growth. Join BioFlorida, Inc. on March 19, at the Miami International Airport Auditorium, where industry leaders, entrepreneurs, and policymakers converge to shape Florida’s healthcare future. No hype, just action. ????Don’t miss out and register today! https://lnkd.in/e6jtEsTF This is your chance to connect directly with people driving change and to showcase your work. ???Hear from Industry leaders, including: Mark Glickman, President & CEO, BioFlorida Rich Daly, CEO,?Catalyst Pharmaceuticals, Inc.?(Keynote Speaker) Jason Matuszewski,?CEO,?BioStem Technologies (OTC: BSEM) Maurice R. Ferre M.D. Ferre, MD,?CEO & Chairman,?INSIGHTEC Dr. Yelena Yesha,?First Knight Foundation Chair of Data Science and AI,?University of Miami Sergey Shukaila, Director, Strategic Accounts for North America,?LeverX Gregory G Mario,?CEO,?TAXIS Pharmaceuticals, Inc. Pharma Andrew S. Duffell, MBA,?President,?Research Park at Florida Atlantic University William Silverman,?Executive Director,?Coulter Program & New Ventures,?University of Miami, Miller School of Medicine Jaap Donath, Ph.D. Donath, PhD, Assistant Executive Director,?Alan B. Levan | NSU Broward Center of Innovation ???DATE:?Wednesday, March 19, 2025 ??TIME:?9:30 am - 2:00 pm ???LOCATION:?Miami International Airport?Auditorium, 4th Floor, Terminal D at Miami International Airport?|?Miami, FL Ready to be part of Florida’s healthcare evolution? Drop a comment: What's the biggest hurdle you've faced in commercializing medical technologies? ???? Share this post to invite others into the conversation! ?? Follow me and Cleveland Clinic Innovations for more insights on healthcare innovation! ?? #clevelandclinic #ClevelandClinicInnovations #healthcare #healthcareinnovation #BioFlorida2025 #lifesciences #medicalinnovation Mark Glickman Ian Leventhal Tara Ann Coleman, MBA Lorrie Albinson, MBA Jessica Manchette
-
Thanks to Opatola James for sharing this and helping raise awareness about the urgent silent threat of antimicrobial resistance (AMR)! ?? ?? #AMR #antimicrobialresistance #antibioticresistance #worldhealth #publichealth #globalhealth #health
Antimicrobial Resistance (AMR) is a growing global health pandemic. As bacteria, viruses, and other microorganisms develop resistance to antibiotics and other antimicrobial treatments, we are faced with the alarming prospect of a future where even the simplest infections become deadly. This poem, "THE SILENT THREAT," aims to raise awareness about the urgent issue of AMR and inspire collective action to combat this growing menace. THE SILENT THREAT Invisible foes, lurking near Resistant strains, our greatest fear A world where cures no longer prevail A future uncertain, with healthcare frail The silent threat of AMR creeps A global crisis, in quiet sweeps Infecting lives, and futures too A menace hidden, yet coming true In hospitals, clinics, and homes so dear AMR's dark shadow looms, always near A constant threat, to young and old A danger that's real, yet often untold The healthcare heroes, on the frontlines stand Fighting resistance, with skilled hands But without awareness, and action bold The silent threat of AMR will never grow old We must unite, to combat this foe Raise awareness, and let knowledge grow Develop new cures, and use them with care For the future of healthcare, awareness is key The clock is ticking, the time is near To confront AMR, and cast out fear Let's join forces, to create a brighter day Where the silent threat of AMR fades away (Composed by Opatola James) American Society for Microbiology Dr Kamlesh Patel World Health Organization TAXIS Pharmaceuticals, Inc. Microbiology Society Yusuf Babatunde
-
-
Thanks to Seegene Inc. for this informative post and the research they're conducting to help fight antimicrobial resistance (AMR). They are using molecular diagnotics to detect AMR-related targets, which could potentially help ensure the right antibiotic treatment, avoiding resistance. TAXIS Pharmaceuticals, Inc. is also researching innovative solutions to AMR. We’re not just treating infections, we’re developing investigational therapies that directly target the bacterial processes driving AMR. You can learn more about TAXIS’ research and development here: https://lnkd.in/geBF25HQ #AMR #antimicrobialresistance #antibioticresistance #DHFRIs #health #GlobalHealth #publichealth #worldhealth #HAIs #MRSA #gonorrhea #supergonorrhea #pneumonia #medicine #innovation #drugdevelopment #pharmaceuticals #pharma #biotech #medtech #lifesciences #biology
?? Rising antimicrobial resistance (#AMR) is making #STIs harder to treat! ??. ?????????????????????? already has high resistance, and ??. ???????????????????? is rapidly catching up. Without accurate diagnosis before treatment, the wrong antibiotics could fuel resistance even more. Seegene’s high #multiplex real-time #PCR assays detect AMR-related targets, ensuring the right treatment from the start, avoiding resistance & enabling faster recovery. See how molecular diagnostics can change the game!??? #Seegene #qPCR #Antimicrobial_Resistance #Molecular_Diagnostics
-
Exciting news! ?? TAXIS Pharmaceuticals, Inc. will be delivering a poster presentation at the BioFlorida, Inc.'s 9th Annual BioFlorida Life Sciences Showcase on March 19, 2025. At TAXIS, we believe that the greatest scientific advancements happen at the intersection of collaboration and innovation. The future of life sciences depends on scientists, entrepreneurs, and investors working together to bring groundbreaking discoveries to fruition. That’s how we overcome major global challenges, like antimicrobial resistance (AMR). TAXIS is committed to combating AMR and saving lives. Our investigational therapies are designed to directly address the root causes of AMR. Learn more on our website: https://lnkd.in/gVC97hgT. Join us as we work together to push the boundaries of medicine and create a healthier future for all! ?? When: March 19, 2025 ??? Where: Miami International Airport Auditorium Don’t hesitate to send a message (https://lnkd.in/gGXjsmEd) if you are attending and would like to meet with TAXIS CEO, Gregory G Mario, to learn more about our research and discuss possible collaboration. #LifeSciences #Innovation #Biotech #Medtech #Collaboration #AMR #HealthcareInnovation #Pharmaceuticals #pharma #investing #startups #innovation #antimicrobialresistance #antibioticresistance #research
-
-
TAXIS Pharmaceuticals, Inc. is uniquely focused on restoring the efficacy of already approved antibiotics to help fight tackle multidrug-resistant infections. We’re targeting the root causes of drug resistance. Our approach goes beyond traditional methods. We’re dismantling the bacteria cellular infrastructure, breaking down barriers, and disrupting the mechanisms that fuel antimicrobial resistance. Find out how TAXIS is pioneering the future with unmatched innovation to save lives on our website: https://lnkd.in/grufgeDG. #antibioticresistance #research #drugdevelopment #pharmaceuticals #investment #startups #biotech #medtech #pharmaceuticals #innovation #investing #startups #drugdiscovery #pharma #research #medicine
-